These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 27036144)

  • 21. New approaches to antimicrobial discovery.
    Lewis K
    Biochem Pharmacol; 2017 Jun; 134():87-98. PubMed ID: 27823963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platforms for antibiotic discovery.
    Lewis K
    Nat Rev Drug Discov; 2013 May; 12(5):371-87. PubMed ID: 23629505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Next-Generation Drug Discovery to Combat Antimicrobial Resistance.
    Niu G; Li W
    Trends Biochem Sci; 2019 Nov; 44(11):961-972. PubMed ID: 31256981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent Progress in Natural-Product-Inspired Programs Aimed To Address Antibiotic Resistance and Tolerance.
    Abouelhassan Y; Garrison AT; Yang H; Chávez-Riveros A; Burch GM; Huigens RW
    J Med Chem; 2019 Sep; 62(17):7618-7642. PubMed ID: 30951303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of SBDD to the discovery of new antibacterial drugs.
    Finn J
    Methods Mol Biol; 2012; 841():291-319. PubMed ID: 22222458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural Products as Platforms To Overcome Antibiotic Resistance.
    Rossiter SE; Fletcher MH; Wuest WM
    Chem Rev; 2017 Oct; 117(19):12415-12474. PubMed ID: 28953368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural Product-Based Antibiotics: Synthesis and SAR-Studies.
    Prusov EV
    Curr Pharm Des; 2016; 22(12):1730-55. PubMed ID: 26769331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Where will new antibiotics come from?
    Walsh C
    Nat Rev Microbiol; 2003 Oct; 1(1):65-70. PubMed ID: 15040181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials.
    O'Connell KM; Hodgkinson JT; Sore HF; Welch M; Salmond GP; Spring DR
    Angew Chem Int Ed Engl; 2013 Oct; 52(41):10706-33. PubMed ID: 24038605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospects for new antibiotics: a molecule-centered perspective.
    Walsh CT; Wencewicz TA
    J Antibiot (Tokyo); 2014 Jan; 67(1):7-22. PubMed ID: 23756684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the structural mechanisms of antibiotic resistance sets the platform for new discovery.
    Reeve SM; Lombardo MN; Anderson AC
    Future Microbiol; 2015; 10(11):1727-33. PubMed ID: 26516790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioactive natural products from novel microbial sources.
    Challinor VL; Bode HB
    Ann N Y Acad Sci; 2015 Sep; 1354():82-97. PubMed ID: 26509922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current challenges in the discovery of novel antibacterials from microbial natural products.
    Genilloud O
    Recent Pat Antiinfect Drug Discov; 2012 Dec; 7(3):189-204. PubMed ID: 22963258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies for the Discovery and Development of New Antibiotics from Natural Products: Three Case Studies.
    Herrmann J; Lukežič T; Kling A; Baumann S; Hüttel S; Petković H; Müller R
    Curr Top Microbiol Immunol; 2016; 398():339-363. PubMed ID: 27738913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of antibacterial activity and minimum inhibitory concentration of larval extract of fly via resazurin-based turbidometric assay.
    Teh CH; Nazni WA; Nurulhusna AH; Norazah A; Lee HL
    BMC Microbiol; 2017 Feb; 17(1):36. PubMed ID: 28209130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Target-based antimicrobial drug discovery.
    Alksne LE; Dunman PM
    Methods Mol Biol; 2008; 431():271-83. PubMed ID: 18287763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges of antibacterial discovery revisited.
    Gwynn MN; Portnoy A; Rittenhouse SF; Payne DJ
    Ann N Y Acad Sci; 2010 Dec; 1213():5-19. PubMed ID: 21058956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs.
    Kim W; Hendricks GL; Lee K; Mylonakis E
    Expert Opin Drug Discov; 2017 Jun; 12(6):625-633. PubMed ID: 28402221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antibiotic resistance crisis, with a focus on the United States.
    Martens E; Demain AL
    J Antibiot (Tokyo); 2017 May; 70(5):520-526. PubMed ID: 28246379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The re-emerging role of microbial natural products in antibiotic discovery.
    Genilloud O
    Antonie Van Leeuwenhoek; 2014 Jul; 106(1):173-88. PubMed ID: 24923558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.